Efficacy, Safety, Blood Kinetics, and (213)Bi Distribution Studies of [(225)Ac]Ac-SibuDAB in Prostate Cancer Patients. Schmitl S, Kretschmer-Chott E, Patronas EM, Kramer G, et al. J Nucl Med 2025 Jun 5:jnumed.125.269655. doi: 10.2967/jnumed.125.269655.

Read + Share

Amedeo Smart

Independent Medical Education

Schmitl S, Kretschmer-Chott E, Patronas EM, Kramer G, et al. Efficacy, Safety, Blood Kinetics, and (213)Bi Distribution Studies of [(225)Ac]Ac-SibuDAB in Prostate Cancer Patients. J Nucl Med 2025 Jun 5:jnumed.125.269655. doi: 10.2967/jnumed.125.269655.
PMID: 40473466